En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer/E-commerce
Digital Media / Internet
Industrial Technology
Life Sciences and Healthcare
Software / TMT
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Hanza Holding AB
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
In Media
M&A Know-how
Macro and markets
Market Snapshots
22 Mar 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research
20 Mar 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research
Biosergen
20 Mar 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
Future Gaming
15 Mar 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
Kancera
13 Mar 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research
InCoax
10 Mar 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research
InCoax
09 Mar 2023
Carlsquare successfully advised VitaMoment on the majority investment by ARCUS Capital
Corporate Finance
08 Mar 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
06 Mar 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research
Zinzino
06 Mar 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research
Risk Intelligence
02 Mar 2023
Carlsquare successfully advised the shareholders of TorAlarm on the sale of a majority stake to BILD, a subsidiary of Axel Springer
Corporate Finance
01 Mar 2023
Carlsquare successfully advised Telio, a portfolio company of Charterhouse Capital Partners, on its acquisition of Gerdes Communications
Corporate Finance
01 Mar 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research
28 Feb 2023
Carlsquare advised the shareholder of Arbeitsschutz-Express on the sale to Bunzl
Corporate Finance
28 Feb 2023
Research update ALM Equity: Write-downs in associates affect results
Equity Research
ALM Equity
28 Feb 2023
First impressions Zinzino, Q4 2022: Again, profitability above our expectations
Equity Research
Zinzino
27 Feb 2023
Carlsquare successfully advised Steuerbot, a subsidiary of Haufe Group, on its acquisition by Taxfix
Corporate Finance
24 Feb 2023
Research Update SBB i Norden Q4 2022: Better earnings outweigh lower NAV
Equity Research
SBB i Norden
23 Feb 2023
First Impression SBB i Norden, Q4 2022: Better earnings capacity than expected
Equity Research
SBB i Norden
1
2
3
…
62